Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male Volunteers

• Status: Completed
• Trial end date: 1969-12-31

Summary

Investigate the bioavailability of BI 1356 BS and of metformin after concomitant multiple oral administration of 10 mg BI 1356 BS tablets and 3 x 850 mg metformin in comparison to BI 1356 BS and metformin given alone

• Phase: Phase 1

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Linagliptin; Metformin